Back to search
FDAFDA · Food and drugs·Recall number D-1033-2020

Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50.

Published March 25, 2020 · Recall initiated: March 13, 2020

Summary

FDA records drug Class II recall D-1033-2020, published March 25, 2020 and initiated March 13, 2020. Recalling firm: Sun Pharmaceutical Industries, Inc.; Status: Terminated; Reported quantity: 172,320 bottles; Lot: Lot #: 3983720, Exp 10/2020; 3990461, 3990464, 3990465, 3990466, 3990470, Exp 11/2020; AA42499, AA42510, AA44468, AA44470, Exp 04/2021; AA55073, AA55074, AA55075, Exp 05/2021; AA61486, Exp 06/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

What to do

Voluntary: Firm initiated · Letter

Get an email if DOXYCYCLINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DOXYCYCLINE
Manufacturer
Sun Pharmaceutical Industries, Inc.
Distributor
Nationwide in the USA
UPC
0363304614015
Lot
Lot #: 3983720, Exp 10/2020; 3990461, 3990464, 3990465, 3990466, 3990470, Exp 11/2020; AA42499, AA42510, AA44468, AA44470, Exp 04/2021; AA55073, AA55074, AA55075, Exp 05/2021; AA61486, Exp 06/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Doxycycline Capsules, USP, 100 mg, 50-count bottle, Rx only, Manufactured by: Ohm Laboratories Inc., New Brunswick, NJ 08901; Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; NDC 63304-616-50. recalled?

Yes. FDA published recall D-1033-2020 on March 25, 2020. Reported hazard: CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DOXYCYCLINE. UPC: 0363304614015.